114 related articles for article (PubMed ID: 16699716)
1. Phenotypic characterization of three clinical isolates of Burkholderia pseudomallei in Ceará, Brazil.
Virginio CG; Teixeira MF; Frota CC; Café VS; Rocha MF; Sidrim JJ
Mem Inst Oswaldo Cruz; 2006 Feb; 101(1):95-7. PubMed ID: 16699716
[TBL] [Abstract][Full Text] [Related]
2. Burkholderia pseudomallei: a case report of a human infection in Ceará, Brazil.
Miralles IS; Maciel Mdo C; Angelo MR; Gondini MM; Frota LH; dos Reis CM; Hofer E
Rev Inst Med Trop Sao Paulo; 2004; 46(1):51-4. PubMed ID: 15057337
[TBL] [Abstract][Full Text] [Related]
3. Burkholderia pseudomallei animal and human isolates from Malaysia exhibit different phenotypic characteristics.
Lee SH; Chong CE; Lim BS; Chai SJ; Sam KK; Mohamed R; Nathan S
Diagn Microbiol Infect Dis; 2007 Jul; 58(3):263-70. PubMed ID: 17350202
[TBL] [Abstract][Full Text] [Related]
4. Raising the Stakes: Loss of Efflux Pump Regulation Decreases Meropenem Susceptibility in Burkholderia pseudomallei.
Sarovich DS; Webb JR; Pitman MC; Viberg LT; Mayo M; Baird RW; Robson JM; Currie BJ; Price EP
Clin Infect Dis; 2018 Jul; 67(2):243-250. PubMed ID: 29394337
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility pattern of clinical isolates of Burkholderia pseudomallei in Bangladesh.
Dutta S; Haq S; Hasan MR; Haq JA
BMC Res Notes; 2017 Jul; 10(1):299. PubMed ID: 28728591
[TBL] [Abstract][Full Text] [Related]
6. Genomic Diversity of Burkholderia pseudomallei in Ceara, Brazil.
Gee JE; Gulvik CA; Castelo-Branco DSCM; Sidrim JJC; Rocha MFG; Cordeiro RA; Brilhante RSN; Bandeira TJPG; Patrício I; Alencar LP; da Costa Ribeiro AK; Sheth M; Deka MA; Hoffmaster AR; Rolim D
mSphere; 2021 Feb; 6(1):. PubMed ID: 33536328
[No Abstract] [Full Text] [Related]
7. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia.
Hassan MR; Vijayalakshmi N; Pani SP; Peng NP; Mehenderkar R; Voralu K; Michael E
Southeast Asian J Trop Med Public Health; 2014 May; 45(3):680-8. PubMed ID: 24974653
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Burkholderia pseudomallei isolated in Thailand and Malaysia.
Radua S; Ling OW; Srimontree S; Lulitanond A; Hin WF; Yuherman ; Lihan S; Rusul G; Mutalib AR
Diagn Microbiol Infect Dis; 2000 Nov; 38(3):141-5. PubMed ID: 11109011
[TBL] [Abstract][Full Text] [Related]
9. Genotypic and phenotypic relationship in Burkholderia pseudomallei indicates colonization with closely related isolates.
Radu S; Lihan S; Idris A; Ling OW; Al-Haddawi MH; Rusul G
Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):760-3. PubMed ID: 10928372
[TBL] [Abstract][Full Text] [Related]
10. Potential misidentification of Burkholderia pseudomallei by API 20NE.
Inglis TJ; Chiang D; Lee GS; Chor-Kiang L
Pathology; 1998 Feb; 30(1):62-4. PubMed ID: 9534210
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility and genetic characterisation of Burkholderia pseudomallei isolated from Malaysian patients.
Khosravi Y; Vellasamy KM; Mariappan V; Ng SL; Vadivelu J
ScientificWorldJournal; 2014; 2014():132971. PubMed ID: 25379514
[TBL] [Abstract][Full Text] [Related]
12. Identification and Characterization of Burkholderia pseudomallei from Localized Pyogenic Infections in Eastern India: A Clinico-Microbiological Study.
Purushotham P; Mohanty S; Chappity P; Mishra TS; Mahapatra A
Am J Trop Med Hyg; 2021 Feb; 104(4):1252-1259. PubMed ID: 33534740
[TBL] [Abstract][Full Text] [Related]
13. Biochemical characteristics of clinical and environmental isolates of Burkholderia pseudomallei.
Wuthiekanun V; Smith MD; Dance DA; Walsh AL; Pitt TL; White NJ
J Med Microbiol; 1996 Dec; 45(6):408-12. PubMed ID: 8958243
[TBL] [Abstract][Full Text] [Related]
14. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
Crowe A; McMahon N; Currie BJ; Baird RW
Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
[TBL] [Abstract][Full Text] [Related]
15. Activity of Ceftolozane-Tazobactam against
Slack A; Parsonson F; Cronin K; Engler C; Norton R
Am J Trop Med Hyg; 2018 Aug; 99(2):281-282. PubMed ID: 29943711
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of bla(PenA) and bla(OXA) in Burkholderia pseudomallei Isolated from Patients at Sappasitthiprasong Hospital and Their Susceptibility to Ceftazidime and Carbapenems.
Panya M; Thirat S; Wanram S; Panomket P; Nilsakul J
J Med Assoc Thai; 2016 Jan; 99 Suppl 1():S12-6. PubMed ID: 26817233
[TBL] [Abstract][Full Text] [Related]
17. Comparison between the antimicrobial susceptibility of Burkholderia pseudomallei to trimethoprim-sulfamethoxazole by standard disk diffusion method and by minimal inhibitory concentration determination.
Lumbiganon P; Tattawasatra U; Chetchotisakd P; Wongratanacheewin S; Thinkhamrop B
J Med Assoc Thai; 2000 Aug; 83(8):856-60. PubMed ID: 10998837
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.
Thibault FM; Hernandez E; Vidal DR; Girardet M; Cavallo JD
J Antimicrob Chemother; 2004 Dec; 54(6):1134-8. PubMed ID: 15509614
[TBL] [Abstract][Full Text] [Related]
19. Highly resistant Burkholderia pseudomallei small colony variants isolated in vitro and in experimental melioidosis.
Häussler S; Rohde M; Steinmetz I
Med Microbiol Immunol; 1999 Nov; 188(2):91-7. PubMed ID: 10753061
[TBL] [Abstract][Full Text] [Related]
20. Preliminary evaluation of the API 20NE and RapID NF plus systems for rapid identification of Burkholderia pseudomallei and B. mallei.
Glass MB; Popovic T
J Clin Microbiol; 2005 Jan; 43(1):479-83. PubMed ID: 15635021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
